<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02913053</url>
  </required_header>
  <id_info>
    <org_study_id>ZonMw733051044</org_study_id>
    <secondary_id>BMBF 01ED1510A</secondary_id>
    <secondary_id>JPND-2014-1</secondary_id>
    <nct_id>NCT02913053</nct_id>
  </id_info>
  <brief_title>The Effects of an Extensive Exercise Program on the Progression of Mild Cognitive Impairment</brief_title>
  <acronym>NeuroExercise</acronym>
  <official_title>The Effects of an Extensive Exercise Program on the Progression of Mild Cognitive Impairment (MCI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Sport University, Cologne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Dublin, Trinity College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bonn</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exercise interventions to prevent dementia and delay cognitive decline have gained&#xD;
      considerable attention in recent years. Human and animal studies have demonstrated that&#xD;
      regular physical activity targets brain function by increasing cognitive reserve. Although&#xD;
      initial studies indicate enhanced cognitive performance in patients with mild cognitive&#xD;
      impairment (MCI) following an exercise intervention, little is known about the effect of an&#xD;
      extensive, controlled and regular exercise regimen on the neuropathology of patients with&#xD;
      MCI.&#xD;
&#xD;
      The aim of this study is to compare a 12- month aerobic exercise programme versus a&#xD;
      stretching and toning (non-aerobic) programme versus a control group on the progression of&#xD;
      cognitive decline in MCI.&#xD;
&#xD;
      It is hypothesized that MCI-related decreases in cognitive and psychomotor functioning will&#xD;
      show less progression or even be improved after a one-year aerobic exercise intervention&#xD;
      compared to a group of patients undergoing stretching and toning exercise as well as to a&#xD;
      control group provided with no intervention.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomised controlled clinical intervention study will take place across three European&#xD;
      sites; the German Sport University Cologne, Germany, University of Nijmegen, The Netherlands&#xD;
      and Trinity College Dublin, Ireland. Seventy-five previously sedentary patients with a&#xD;
      clinical diagnosis of MCI will be recruited at each site. Participants will be randomised to&#xD;
      one of three intervention arms. One group will receive a standardised one-year extensive&#xD;
      aerobic exercise intervention (3 units of 45min / week). The second group will complete&#xD;
      stretching and toning (non-aerobic) exercise (3 units of 45min / week) and the third group&#xD;
      will receive usual care. Change in all outcomes will be measured at baseline (T0), after six&#xD;
      months (T1) and after 12 months (T2).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">December 2018</completion_date>
  <primary_completion_date type="Actual">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive performance</measure>
    <time_frame>One year</time_frame>
    <description>Cognitive performance will be assessed by an extensive neuropsychological test battery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global cognitive function</measure>
    <time_frame>One year</time_frame>
    <description>MoCA (Montreal Cognitive Assessment)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular fitness</measure>
    <time_frame>One year</time_frame>
    <description>(sub)maximal ergometer exercise test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>One year</time_frame>
    <description>Activity monitoring with accelerometers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health related Quality of Life</measure>
    <time_frame>One year</time_frame>
    <description>Health Related Quality of Life for People with Dementia (DemQOL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depressive symptoms</measure>
    <time_frame>One year</time_frame>
    <description>Center for Epidemiologic Studies Depression (CES-D)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuroticism-Extraversion-Openness-Five Factor Inventory (NEO-FFI)</measure>
    <time_frame>One year</time_frame>
    <description>Personality traits assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timed up and Go (TUG)</measure>
    <time_frame>One year</time_frame>
    <description>Frailty measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hand grip strength</measure>
    <time_frame>One year</time_frame>
    <description>Frailty measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 second chair stand</measure>
    <time_frame>One year</time_frame>
    <description>Frailty measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epigenetics</measure>
    <time_frame>One year</time_frame>
    <description>Genotyping of the Apolipoprotein E (APOE) 4 allele in venous blood.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain imaging</measure>
    <time_frame>6 months</time_frame>
    <description>Magnetic Resonance Imaging (MRI) scan: brain structure</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">183</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Aerobic exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Stretching and Toning</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care: Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Aerobic exercise</intervention_name>
    <description>Patients with mild cognitive impairment will undergo a one-year aerobic exercise program of 3 units of 45 min / week</description>
    <arm_group_label>Aerobic exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Non-aerobic exercise</intervention_name>
    <description>Patients with mild cognitive impairment will undergo a one-year stretching and toning (non-aerobic) exercise program of 3 units of 45 min / week</description>
    <arm_group_label>Stretching and Toning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) according&#xD;
             to the Albert et al (2011) criteria&#xD;
&#xD;
          -  Montreal Cognitive Assessment (MoCA) (Nasreddine et al. 2005) score 18-26&#xD;
&#xD;
          -  Stable medical condition for more than 6 months&#xD;
&#xD;
          -  Stable medications for more than 3 months&#xD;
&#xD;
          -  Adequate visual and auditory acuity to complete neuropsychological testin&#xD;
&#xD;
          -  Electrocardiogram without significant abnormalities that might interfere with the&#xD;
             study&#xD;
&#xD;
          -  Physical ability sufficient to allow performance of endurance exercise training&#xD;
&#xD;
          -  Capacity to provide written and dated informed consent form&#xD;
&#xD;
          -  Medical clearance to undergo a symptom-limited cardiopulmonary exercise test and&#xD;
             extensive aerobic exercise training&#xD;
&#xD;
          -  Participants recruited from the community via newspaper articles and community&#xD;
             advertisement will complete additional testing to determine MCI status. Participants&#xD;
             must score â‰¤1.5 standard deviation (SD) of cut-off scores on episodic memory test&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of AD or other type of dementia&#xD;
&#xD;
          -  History of familial early-onset dementia&#xD;
&#xD;
          -  Enrollment onto any investigational drug study&#xD;
&#xD;
          -  History in the past 2 years of epileptic seizures (Participants with epilepsy who have&#xD;
             been stable off medication and seizure free for 2 years may be included)&#xD;
&#xD;
          -  Any major psychiatric disorder (a clinical diagnosis of major depressive disorder,&#xD;
             bipolar or schizophrenia)&#xD;
&#xD;
          -  Past history or MRI evidence of brain damage, including significant trauma, stroke,&#xD;
             hydrocephalus, mental retardation, or serious neurological disorder&#xD;
&#xD;
          -  Carotid stent or severe stenosis&#xD;
&#xD;
          -  History of myocardial infarction within previous year congestive heart failure (New&#xD;
             York Heart Association Class II, III or IV)&#xD;
&#xD;
          -  Uncontrolled hypertension or hypotension (systolic blood pressure &gt;200 mm Hg and/or&#xD;
             diastolic blood pressure &gt;110 mm Hg at rest)&#xD;
&#xD;
          -  Unstable cardiac, renal, lung, liver, or other severe chronic disease&#xD;
&#xD;
          -  Type 2 diabetes mellitus with hypoglycemia in the last 3 months&#xD;
&#xD;
          -  Significant history of alcoholism or drug abuse within last 10 years&#xD;
&#xD;
          -  Significant obesity limiting active participation in the exercise program&#xD;
&#xD;
          -  Engagement in moderate-intensity aerobic exercise training for more than 30 minutes, 3&#xD;
             times per week, during past 2 years&#xD;
&#xD;
          -  History of vitamin B12 deficiency or hypothyroidism (stable treatment for at least 3&#xD;
             months is allowed)&#xD;
&#xD;
          -  Serious or non-healing wound, ulcer, or bone fracture&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Schneider, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>German Sport University, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brian Lawlor, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Trinity College Dublin, Ireland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marcel Olde Rikkert, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University, Netherlands</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>German Sport University</name>
      <address>
        <city>Cologne</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trinity College Dublin</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radboud University Medical Center</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Ireland</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>August 17, 2016</study_first_submitted>
  <study_first_submitted_qc>September 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2016</study_first_posted>
  <last_update_submitted>November 13, 2019</last_update_submitted>
  <last_update_submitted_qc>November 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

